Indirect human exposure to pharmaceuticals via drinking water.

There are numerous observations of pharmaceuticals (or their metabolites) as contaminants in wastewater, surface water and groundwater. This implies a potential for indirect human exposure to pharmaceuticals via drinking water supplies. Various effect benchmarks may be employed in an evaluation of the significance of such indirect exposure. In this study a comparison was made between reported concentrations of pharmaceuticals in German drinking water and therapeutic dose. The margin between potential indirect daily exposure via drinking water and daily therapeutic dose was at least three orders of magnitude and typically much more. For certain compounds it was also possible to benchmark exposure against ADIs derived within the context of meat and food stuff residues following veterinary use. In all cases potential exposure was less than the ADIs, similarly suggesting that for these compounds there are no substantial concerns with regards to indirect exposure via drinking water.

[1]  F. Christensen.  Pharmaceuticals in the environment--a human risk? , 1998, Regulatory toxicology and pharmacology : RTP.

[2]  Martin Kampmann,et al.  Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater? , 2003, Water research.

[3]  H. Steinhart,et al.  Natural occurrence of steroid hormones in food , 1998 .

[4]  H. Steinhart,et al.  Occurrence of hormonally active compounds in food: a review , 1999 .

[5]  K. Ballschmiter,et al.  Determination of endocrine-disrupting phenolic compounds and estrogens in surface and drinking water by HRGC-(NCI)-MS in the picogram per liter range. , 2001, Environmental science & technology.

[6]  Thomas A. Ternes,et al.  Analytical methods for the determination of pharmaceuticals in aqueous environmental samples , 2001 .

[7]  Peter Adler,et al.  Vorkommen natürlicher und synthetischer östrogener Steroide in Wässern des süd- und mitteldeutschen Raumes , 2001 .

[8]  Martin Oldenburg,et al.  Source control in urban sanitation and waste management: Ten systems with reuse of resources , 1999 .

[9]  Ettore Zuccato,et al.  Presence of therapeutic drugs in the environment , 2000, The Lancet.

[10]  G. Aherne,et al.  The relevance of the presence of certain synthetic steroids in the aquatic environment , 1989, The Journal of pharmacy and pharmacology.

[11]  Mervyn L Richardson,et al.  Risk assessment of chemicals in the environment , 1988 .

[12]  K. Kümmerer.  Pharmaceuticals in the Environment , 2001 .

[13]  H. Kay.  Environmental Health Criteria , 1980 .

[14]  Edward V. Sargent,et al.  A Human Health Risk Assessment of Pharmaceuticals in the Aquatic Environment , 2002 .

[15]  Thomas Ternes,et al.  Pharmaceuticals and Metabolites as Contaminants of the Aquatic Environment , 2001 .

[16]  G. Aherne,et al.  Cytotoxic drugs and the aquatic environment: estimation of bleomycin in river and water samples , 1990, The Journal of pharmacy and pharmacology.

[17]  T. Heberer,et al.  Vorkommen von Clofibrinsäure in aquatischen System: Führt die therapeutische Anwendung zu einer Belastung von Oberflächen-, Grund- und Trinkwasser? , 1994 .

[18]  W. Gujer,et al.  The concept of sustainable Urban Water Management , 1997 .

[20]  V Marks,et al.  The role of immunoassay in the analysis of microcontaminants in water samples. , 1985, Ecotoxicology and environmental safety.

[21]  M L Richardson,et al.  The fate of pharmaceutical chemicals in the aquatic environment , 1985, The Journal of pharmacy and pharmacology.

[22]  S. Webb,et al.  A Data Based Perspective on the Environmental Risk Assessment of Human Pharmaceuticals III — Indirect Human Exposure , 2004 .

[23]  Frank Sacher,et al.  Removal of pharmaceuticals during drinking water treatment. , 2002, Environmental science & technology.

[24]  W. Cooper.  Chemistry in water reuse , 1981 .